Search

Robert W. Downs

Examiner (ID: 17152)

Most Active Art Unit
2308
Art Unit(s)
2762, 4762, 2309, 2308, 2165
Total Applications
581
Issued Applications
448
Pending Applications
24
Abandoned Applications
109

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18284224 [patent_doc_number] => 20230099696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN [patent_app_type] => utility [patent_app_number] => 17/908492 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9050 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908492 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908492
NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN Mar 4, 2021 Pending
Array ( [id] => 18552424 [patent_doc_number] => 20230250433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER [patent_app_type] => utility [patent_app_number] => 17/905124 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23324 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905124 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905124
METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER Feb 25, 2021 Pending
Array ( [id] => 16898905 [patent_doc_number] => 20210177821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => Androgen Receptor Modulator And Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/185420 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185420 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/185420
Androgen Receptor Modulator And Uses Thereof Feb 24, 2021 Abandoned
Array ( [id] => 18589227 [patent_doc_number] => 11738099 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Molecular probes and methods of use [patent_app_type] => utility [patent_app_number] => 17/182997 [patent_app_country] => US [patent_app_date] => 2021-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 44 [patent_no_of_words] => 26730 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182997 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182997
Molecular probes and methods of use Feb 22, 2021 Issued
Array ( [id] => 16932307 [patent_doc_number] => 20210198196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => NON-AGGREGATING HEPTAMETHINE CYANINE FLUOROPHORES FOR IN VIVO IMAGING [patent_app_type] => utility [patent_app_number] => 17/179217 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15756 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179217 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179217
Non-aggregating heptamethine cyanine fluorophores for in vivo imaging Feb 17, 2021 Issued
Array ( [id] => 18252718 [patent_doc_number] => 20230079757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => METHODS AND MATERIALS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/800008 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800008 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/800008
METHODS AND MATERIALS FOR TREATING CANCER Feb 17, 2021 Abandoned
Array ( [id] => 17065917 [patent_doc_number] => 20210268132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => METHODS OF SEQUESTERING TARGET ELEMENTS [patent_app_type] => utility [patent_app_number] => 17/175228 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22632 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175228 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/175228
METHODS OF SEQUESTERING TARGET ELEMENTS Feb 11, 2021 Pending
Array ( [id] => 17050767 [patent_doc_number] => 20210260201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF INFECTIONS AND OTHER DISEASES [patent_app_type] => utility [patent_app_number] => 17/172293 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172293 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/172293
EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF INFECTIONS AND OTHER DISEASES Feb 9, 2021 Abandoned
Array ( [id] => 16992172 [patent_doc_number] => 20210230592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors [patent_app_type] => utility [patent_app_number] => 17/158132 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158132 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/158132
Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors Jan 25, 2021 Abandoned
Array ( [id] => 16822797 [patent_doc_number] => 20210138090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => uPAR targeting peptide for use in peroperative optical imaging of invasive cancer [patent_app_type] => utility [patent_app_number] => 17/150133 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10034 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150133 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/150133
uPAR targeting peptide for use in peroperative optical imaging of invasive cancer Jan 14, 2021 Abandoned
Array ( [id] => 20621677 [patent_doc_number] => 12589171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => 177-Lu labeled peptide for site-specific uPAR-targeting [patent_app_type] => utility [patent_app_number] => 17/144067 [patent_app_country] => US [patent_app_date] => 2021-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4647 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144067 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/144067
177-Lu labeled peptide for site-specific uPAR-targeting Jan 6, 2021 Issued
Array ( [id] => 18283728 [patent_doc_number] => 20230099200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT OF CXCR4 EXPRESSING TUMORS [patent_app_type] => utility [patent_app_number] => 17/789398 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789398 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789398
RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT OF CXCR4 EXPRESSING TUMORS Dec 22, 2020 Pending
Array ( [id] => 17968244 [patent_doc_number] => 11485758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Bi-terminal pegylated integrin-binding peptides and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/131324 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 37663 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131324 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/131324
Bi-terminal pegylated integrin-binding peptides and methods of use thereof Dec 21, 2020 Issued
Array ( [id] => 18525505 [patent_doc_number] => 11712485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Triazine based radiopharmaceuticals and radioimaging agents [patent_app_type] => utility [patent_app_number] => 17/129825 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16829 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129825 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/129825
Triazine based radiopharmaceuticals and radioimaging agents Dec 20, 2020 Issued
Array ( [id] => 18027840 [patent_doc_number] => 11511001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Radiolabeled anti-LAG3 antibodies for immuno-PET imaging [patent_app_type] => utility [patent_app_number] => 17/127618 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28887 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127618 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127618
Radiolabeled anti-LAG3 antibodies for immuno-PET imaging Dec 17, 2020 Issued
Array ( [id] => 18341294 [patent_doc_number] => 11638763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-02 [patent_title] => Nanoallergens and uses thereof [patent_app_type] => utility [patent_app_number] => 17/126616 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 84 [patent_no_of_words] => 22464 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 392 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126616 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/126616
Nanoallergens and uses thereof Dec 17, 2020 Issued
Array ( [id] => 18166765 [patent_doc_number] => 20230033370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 [patent_app_type] => utility [patent_app_number] => 17/782910 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782910 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782910
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 Dec 15, 2020 Abandoned
Array ( [id] => 18178948 [patent_doc_number] => 20230039677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 [patent_app_type] => utility [patent_app_number] => 17/782931 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782931 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782931
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 Dec 15, 2020 Abandoned
Array ( [id] => 18179279 [patent_doc_number] => 20230040008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES [patent_app_type] => utility [patent_app_number] => 17/786768 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6899 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786768 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/786768
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES Dec 15, 2020 Pending
Array ( [id] => 16883862 [patent_doc_number] => 20210170057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => HER2 BINDERS [patent_app_type] => utility [patent_app_number] => 17/117697 [patent_app_country] => US [patent_app_date] => 2020-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117697 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/117697
HER2 binders Dec 9, 2020 Issued
Menu